Integrated Filing — IndAS



General information about company
Scrip Code 532843
NSE Symbol FORTIS
MSEI Symbol NOTLISTED
ISIN INE061F01013
Name of company Fortis Healthcare Limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-Apr-2024
Date of end of financial year 31-Mar-2025
Date of board meeting when results were approved 20-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 08-May-2025
Description of presentation currency INR (in Actuals)
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Single segment
Description of single segment Healthcare services
Start date and time of board meeting 20-May-2025   09:00:00
End date and time of board meeting 20-May-2025   17:30:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 2025-05-20
Indicate Company website link for updated RPT policy of the Company https://www.fortishealthcare.com/investors/policies-&-code/483?page=1
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? Yes



Financial Results Ind-AS
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Income
Revenue from operations 3884700000 14458900000
Other income 249900000 1985500000
Total income 4134600000 16444400000
2 Expenses
(a) Cost of materials consumed 0 0
(b) Purchases of stock-in-trade 989300000 3838900000
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade -6000000 -37900000
(d) Employee benefit expense 550500000 2071300000
(e) Finance costs 519100000 1115800000
(f) Depreciation, depletion and amortisation expense 305200000 1129200000
(f) Other Expenses
1 Professional and consultation fees to doctors 763700000 2716600000
2 Other Expenses 877600000 3314900000
Total other expenses 1641300000 6031500000
Total expenses 3999400000 14148800000
3 Total profit before exceptional items and tax 135200000 2295600000
4 Exceptional items -524200000 -1151400000
5 Total profit before tax -389000000 1144200000
6 Tax expense
7 Current tax -26700000 301400000
8 Deferred tax 60000000 204900000
9 Total tax expenses 33300000 506300000
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0 0
11 Net Profit Loss for the period from continuing operations -422300000 637900000
12 Profit (loss) from discontinued operations before tax 0 0
13 Tax expense of discontinued operations 0 0
14 Net profit (loss) from discontinued operation after tax 0 0
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0 0
16 Total profit (loss) for period -422300000 637900000
17 Other comprehensive income net of taxes -7100000 -14500000
18 Total Comprehensive Income for the period -429400000 623400000
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 7549600000 7549600000
Face value of equity share capital 10 10
27 Details of debt securities
22 Reserves excluding revaluation reserve 83190400000
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations -0.56 0.84
Diluted earnings (loss) per share from continuing operations -0.56 0.84
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations -0.56 0.84
Diluted earnings (loss) per share from continuing and discontinued operations -0.56 0.84
24 Debt equity ratio 0.0022 0.0022
25 Debt service coverage ratio 0.0306 0.0205
26 Interest service coverage ratio 0.0185 0.0407
27 Disclosure of notes on financial results



Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities
Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2024
Date of end of reporting period 31-Mar-2025
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 8914900000
Capital work-in-progress 423200000
Investment property 0
Goodwill 272200000
Other intangible assets 62600000
Intangible assets under development 700000
Biological assets other than bearer plants 0
Investments accounted for using equity method 0
Non-current financial assets
Non-current investments 101782500000
Trade receivables, non-current 0
Loans, non-current 166900000
Other non-current financial assets 8800000
Total non-current financial assets 101958200000
Deferred tax assets (net) 181000000
Other non-current assets 3349600000
Total non-current assets 115162400000
2 Current assets
Inventories 167200000
Current financial asset
Current investments 0
Trade receivables, current 1813200000
Cash and cash equivalents 489600000
Bank balance other than cash and cash equivalents 4900000
Loans, current 862300000
Other current financial assets 482800000
Total current financial assets 3652800000
Current tax assets (net) 928900000
Other current assets 79300000
Total current assets 4828200000
3 Non-current assets classified as held for sale 0
4 Regulatory deferral account debit balances and related deferred tax Assets 0
Total assets 119990600000
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 7549600000
Other equity 83190400000
Total equity attributable to owners of parent 90740000000
Non controlling interest
Total equity 90740000000
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 19009000000
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0
Total Trade payable 0
Other non-current financial liabilities 0
Total non-current financial liabilities 19009000000
Provisions, non-current 294600000
Deferred tax liabilities (net) 0
Deferred government grants, Non-current 0
Other non-current liabilities 0
Total non-current liabilities 19303600000
Current liabilities
Current financial liabilities
Borrowings, current 1376300000
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 154200000
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 6540900000
Total Trade payable 6695100000
Other current financial liabilities 1297300000
Total current financial liabilities 9368700000
Other current liabilities 330300000
Provisions, current 248000000
Current tax liabilities (Net) 0
Deferred government grants, Current 0
Total current liabilities 9947000000
3 Liabilities directly associated with assets in disposal group classified as held for sale 0
4 Regulatory deferral account credit balances and related deferred tax liability 0
Total liabilities 29250600000
Total equity and liabilites 119990600000
Disclosure of notes on assets and liabilities



Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Jan-2025 01-Apr-2024
Date of end of reporting period 31-Mar-2025 31-Mar-2025
Whether accounts are audited or unaudited Audited Audited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Remeasurements of the defined benefit liabilities -9500000 -19400000
Total Amount of items that will not be reclassified to profit and loss -9500000 -19400000
2 Income tax relating to items that will not be reclassified to profit or loss -2400000 -4900000
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss
5 Total Other comprehensive income -7100000 -14500000



Cash flow statement, indirect
Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-Apr-2024
B Date of end of reporting period 31-Mar-2025
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Standalone
Part I Blue color marked fields are non-mandatory.
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 1144200000
Adjustments for reconcile profit (loss)
Adjustments for finance costs 1115800000
Adjustments for decrease (increase) in inventories -37900000
Adjustments for decrease (increase) in trade receivables, current -594900000
Adjustments for decrease (increase) in trade receivables, non-current 0
Adjustments for decrease (increase) in other current assets -19600000
Adjustments for decrease (increase) in other non-current assets 5500000
Adjustments for other financial assets, non-current -7600000
Adjustments for other financial assets, current 700000
Adjustments for other bank balances 200000
Adjustments for increase (decrease) in trade payables, current 1509500000
Adjustments for increase (decrease) in trade payables, non-current 0
Adjustments for increase (decrease) in other current liabilities 83900000
Adjustments for increase (decrease) in other non-current liabilities 0
Adjustments for depreciation and amortisation expense 1129200000
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 1151400000
Adjustments for provisions, current 21900000
Adjustments for provisions, non-current 119700000
Adjustments for other financial liabilities, current 820300000
Adjustments for other financial liabilities, non-current 0
Adjustments for unrealised foreign exchange losses gains 0
Adjustments for dividend income 702300000
Adjustments for interest income 1282600000
Adjustments for share-based payments 0
Adjustments for fair value losses (gains) 100000
Adjustments for undistributed profits of associates 0
Other adjustments for which cash effects are investing or financing cash flow -1100300000
Other adjustments to reconcile profit (loss) 0
Other adjustments for non-cash items -37300000
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0
Total adjustments for reconcile profit (loss) 2175700000
Net cash flows from (used in) operations 3319900000
Dividends received 0
Interest paid 0
Interest received 0
Income taxes paid (refund) -20300000
Other inflows (outflows) of cash 0
Net cash flows from (used in) operating activities 3340200000
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0
Cash flows used in obtaining control of subsidiaries or other businesses 0
Other cash receipts from sales of equity or debt instruments of other entities 3249600000
Other cash payments to acquire equity or debt instruments of other entities 17777400000
Other cash receipts from sales of interests in joint ventures 0
Other cash payments to acquire interests in joint ventures 0
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0
Proceeds from sales of property, plant and equipment 3400000
Purchase of property, plant and equipment 3651900000
Proceeds from sales of investment property 0
Purchase of investment property 0
Proceeds from sales of intangible assets 0
Purchase of intangible assets 0
Proceeds from sales of intangible assets under development 0
Purchase of intangible assets under development 0
Proceeds from sales of goodwill 0
Purchase of goodwill 0
Proceeds from biological assets other than bearer plants 0
Purchase of biological assets other than bearer plants 0
Proceeds from government grants 0
Proceeds from sales of other long-term assets 0
Purchase of other long-term assets 0
Cash advances and loans made to other parties 2838800000
Cash receipts from repayment of advances and loans made to other parties 764100000
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0
Dividends received 702300000
Interest received 2837800000
Income taxes paid (refund) 0
Other inflows (outflows) of cash 988800000
Net cash flows from (used in) investing activities -15722100000
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0
Payments from changes in ownership interests in subsidiaries 0
Proceeds from issuing shares 0
Proceeds from issuing other equity instruments 0
Payments to acquire or redeem entity's shares 0
Payments of other equity instruments 0
Proceeds from exercise of stock options 0
Proceeds from issuing debentures notes bonds etc 15500000000
Proceeds from borrowings 19600000
Repayments of borrowings 796700000
Payments of lease liabilities 479500000
Dividends paid 753400000
Interest paid 730900000
Income taxes paid (refund) 0
Other inflows (outflows) of cash 0
Net cash flows from (used in) financing activities 12759100000
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 377200000
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0
Net increase (decrease) in cash and cash equivalents 377200000
Cash and cash equivalents cash flow statement at beginning of period 53700000
Cash and cash equivalents cash flow statement at end of period 430900000





Details of Impact of Audit Qualification
Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 M/s BSR CO LLP Yes 31-Jul-2025


Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)
Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 Agilus Diagnostics Limited Agilus Diagnostics Nepal Private Limited (Formerly known as SRL Diagnostic (Nepal) Private limited) Joint venture company Any other transaction Investments (at net book value) 0 Nil 0 25145000 24982000
2 Agilus Diagnostics Limited Agilus Diagnostics Nepal Private Limited Joint venture company Sale of goods or services 34031000 Nil 15792000 43604000 55083000
3 Agilus Diagnostics Limited Fortis C-Doc Healthcare Limited Joint venture company Sale of goods or services 8466000 Nil 2592000 35726000 34010000
4 Agilus Diagnostics Limited Gleneagles Healthcare India Pvt Limited Enterprises owned or significantly controlled/influenced by subsidiary of holding/ultimate holding company Sale of goods or services 50031000 Nil 27743000 17511000 12176000
5 Agilus Diagnostics Limited Lanka Hospitals Diagnostics (Pvt) Ltd Associate Company Sale of goods or services 5018000 Nil 1909000 320000 2254000
6 Agilus Diagnostics Limited Agilus Diagnostics Nepal Private Limited Joint venture company Any other transaction Expense incurred on behalf of company by 3131000 Nil 1739000 4612000 6575000
7 Agilus Diagnostics Limited Ms. Suvalaxmi Chakrabarty Independent Director Any other transaction Director Sitting fees 1200000 Nil 600000 0 0
8 Agilus Diagnostics Limited Lanka Hospitals Diagnostics (Pvt) Ltd Associate Company Loan 0 Nil 0 397000 397000
9 Agilus Diagnostics Limited Bharat Insecticides Limited Enterprises owned or significantly controlled/influenced by subsidiary of holding/ultimate holding company Any other transaction Trade Receivables 0 Nil 0 31000 31000
10 Agilus Diagnostics Limited Centre for Digestive and Kidney Diseases (India) Private Limited Enterprises owned or significantly controlled/influenced by subsidiary of holding/ultimate holding company Any other transaction Trade Receivables 0 Nil 0 12000 12000
11 Agilus Diagnostics Limited Mr. Indrajit Banerjee Independent Director Any other transaction Director Sitting Fees 400000 Nil 400000 0 0
12 Agilus Diagnostics Limited Agilus Diagnostics Nepal Private Limited (Formerly known as SRL Diagnostic (Nepal) Private limited) Joint venture company Any other transaction Gross Investments (net of sale proceeds) 0 Nil 0 0 15000000
13 Escorts Heart Institute and Research Centre Limited Fortis C-Doc Healthcare Limited Joint venture company Any other transaction Expenses incurred by the company on behalf 0 Nil 0 20612000 19815000
14 Escorts Heart Institute and Research Centre Limited Fortis C-Doc Healthcare Limited Joint venture company Any other transaction Collection by company on behalf of 0 Nil 197000 0 0
15 Escorts Heart Institute and Research Centre Limited Acibadem Teknoloj A.S Enterprises owned or significantly controlled/influenced by subsidiary of holding/ultimate holding company Any other transaction Intangible asset acquired 0 Nil 10400000 0 3625000
16 Escorts Heart Institute and Research Centre Limited Fortis C-Doc Healthcare Limited Joint venture company Any other transaction Sale of goods or services 0 Nil 547000 0 0
17 Escorts Heart Institute and Research Centre Limited Fortis C-Doc Healthcare Limited Joint venture company Any other transaction Hospital services given to group employees of 0 Nil 242000 0 0
18 Escorts Heart Institute and Research Centre Limited Fortis C-Doc Healthcare Limited Joint venture company Any other transaction Hospital services taken for employees from 0 Nil 448000 0 0
19 Escorts Heart Institute and Research Centre Limited Fortis C-Doc Healthcare Limited Joint venture company Any other transaction Transfer of employee benefit liability to company from 0 Nil 4000 0 0
20 Escorts Heart Institute and Research Centre Limited Fortis C-Doc Healthcare Limited Joint venture company Any other transaction Transfer of medical consumables and drugs to 0 Nil 7000 0 0
21 Fortis Global Healthcare (Mauritius) Limited Mauritius International Trust Company Limited Enterprises significantly influenced by KMP and their relatives Any other transaction Legal and Professional fees 0 Nil 480000 334000 512000
22 Fortis Health management limited Acibadem Teknoloj A.S Enterprises owned or significantly controlled/influenced by subsidiary of holding/ultimate holding company Any other transaction Intangible asset acquired 0 Nil 312000 0 443000
23 Fortis Healthcare International Limited RHT Health Trust Associate Company Any other transaction Investments (at net book value) 0 Nil 0 274904000 0
24 Fortis Healthcare International Limited Mauritius International Trust Company Limited Enterprises significantly influenced by KMP and their relatives Any other transaction Legal and Professional fees 0 Nil 6000 335000 524000
25 Fortis Healthcare International Limited RHT Health Trust Associate Company Any other transaction Gross Investments (net of sale proceeds) 0 Nil 0 0 6085375000
26 Fortis Healthcare International Pte Limited Lanka Hospitals Corporation Plc Associate Company Any other transaction Investments (at net book value) 0 Nil 0 1452404000 1396711000
27 Fortis Healthcare International Pte Limited RHT Health Trust Associate Company Any other transaction Investments (at net book value) 0 Nil 0 0 268065000
28 Fortis Healthcare International Pte Limited Lanka Hospitals Corporation Plc Associate Company Any other transaction Gross Investments (net of sale proceeds) 0 Nil 0 0 1976282000
29 Fortis Healthcare International Pte Limited Lanka Hospitals Corporation Plc Associate Company Any other transaction Provision for Investment 0 Nil 0 0 967624000
30 Fortis Healthcare Limited Acibadem Teknoloj A.S Enterprises owned or significantly controlled/influenced by subsidiary of holding/ultimate holding company Any other transaction Intangible asset acquired 19000000 Nil 1765000 3878000 3095000
31 Fortis Healthcare Limited Dr. Ashutosh Raghuvanshi Managing Director and Chief Executive Officer Any other transaction Remuneration 109400000 Nil 33532000 0 0
32 Fortis Healthcare Limited Mr. Vivek Kumar Goyal Chief Financial Officer Any other transaction Remuneration 66417000 Nil 15355000 0 0
33 Fortis Healthcare Limited Mr. satyendra chauhan Company Secretary Any other transaction Remuneration 16233000 Nil 5430000 0 0
34 Fortis Healthcare Limited Mr. Indrajit Banerjee Independent Director Any other transaction Remuneration 8673000 Nil 4337000 0 0
35 Fortis Healthcare Limited Ms. Suvalaxmi Chakrabarty Independent Director Any other transaction Remuneration 8673000 Nil 4337000 0 0
36 Fortis Healthcare Limited Ms. Shailaja Chandra Independent Director Any other transaction Remuneration 8673000 Nil 4337000 0 0
37 Fortis Healthcare Limited Mr. Indrajit Banerjee Independent Director Any other transaction Director Sitting Fees 4720000 Nil 2006000 0 0
38 Fortis Healthcare Limited Ms. Suvalaxmi Chakrabarty Independent Director Any other transaction Director Sitting Fees 3186000 Nil 1416000 0 0
39 Fortis Healthcare Limited Ms. Shailaja Chandra Independent Director Any other transaction Director Sitting Fees 4956000 Nil 2242000 0 0
40 Fortis Healthcare Limited Mr. Dilip Kadambi (Paid to Northern TK Venture Pte Ltd) Non-Executive Non-Independent Director Any other transaction Director Sitting Fees 1652000 Nil 708000 0 0
41 Fortis Healthcare Limited Mr. Mehmet Ali Aydinlar Additional Director Any other transaction Director Sitting Fees 1416000 Nil 236000 0 0
42 Fortis Healthcare Limited Ashok Pandit Non-Executive Non-Independent Director Any other transaction Director Sitting Fees 3068000 Nil 1180000 0 0
43 Fortis Healthcare Limited Mitsui and Co. Ltd. (Mr.Tomo Nagahiro) Additional Director Any other transaction Director Sitting Fees 1416000 Nil 472000 0 0
44 Fortis Healthcare Limited Mr. Prem Kumar Nair Non-Executive Non-Independent Director Any other transaction Director Sitting Fees 2124000 Nil 826000 0 0
45 Fortis Healthcare Limited Mitsui and Co. Ltd. (Mr.Tomo Nagahiro) Additional Director Any other transaction Reimbursement of expenses 3100000 Nil 341000 0 0
46 Fortis Healthcare Limited Mr. Mehmet Ali Aydinlar Additional Director Any other transaction Reimbursement of expenses 8500000 Nil 2286000 0 0
47 Fortis Healthcare Limited Lanka Hospitals Corporation Plc Associate Company Any other transaction Impairment on investment in 0 Nil 142770000 0 0
48 Fortis Healthcare Limited Lanka Hospitals Corporation Plc Associate Company Any other transaction Provision for investment 0 Nil 0 824854000 0
49 Fortis Healthcare Limited Fortis C-Doc Healthcare Limited Joint venture company Any other transaction Other balance recoverable 0 Nil 0 2839000 2839000
50 Fortis Healthcare Limited Fortis C-Doc Healthcare Limited Joint venture company Any other transaction Trade Receivable 0 Nil 0 2463000 0
51 Fortis Healthcare Limited Fortis C-Doc Healthcare Limited Joint venture company Any other transaction Transfer of Employee Liability from 0 Nil 3000 0 0
52 Fortis Healthcare Limited Mr. Leo Puri Independent Director Any other transaction Remuneration 6068000 Nil 6068000 0 0
53 Fortis Healthcare Limited Fortis C-Doc Healthcare Limited Joint venture company Any other transaction Hospital services taken for employees from 0 Nil 40000 0 0
54 Fortis Healthcare Limited Mr. Leo Puri Independent Director Any other transaction Director Sitting fees 472000 Nil 472000 0 0
55 Fortis Healthcare Limited Mr. Takeshi Saito Independent Director Any other transaction Reimbursement of expenses 150000 Nil 150000 0 0
56 Fortis Healthcare Limited Fortis CSR Foundation Joint venture company Any other transaction Gross Investments 0 Nil 0 0 500000
57 Fortis Hospitals Limited Fortis C-Doc Healthcare Limited Joint venture company Sale of goods or services 0 Nil 0 477000 0
58 Fortis Hospitals Limited Fortis C-Doc Healthcare Limited Joint venture company Any other transaction Consultation fees to doctors 0 Nil 4466000 371000 137000
59 Fortis Hospitals Limited Acibadem Teknoloj A.S Enterprises owned or significantly controlled/influenced by subsidiary of holding/ultimate holding company Any other transaction Intangible asset acquired 0 Nil 14142000 24389000 17418000
60 Fortis Hospitals Limited Fortis C-Doc Healthcare Limited Joint venture company Any other transaction Allowances for Interest accrued on loans recoverable 0 Nil 3833000 0 0
61 Fortis Hospitals Limited Fortis C-Doc Healthcare Limited Joint venture company Any other transaction Gross Investments 0 Nil 0 192285000 192285000
62 Fortis Hospitals Limited Fortis C-Doc Healthcare Limited Joint venture company Any other transaction Provision for Investment 0 Nil 0 192285000 192285000
63 Fortis Hospitals Limited Fortis C-Doc Healthcare Limited Joint venture company Any other transaction Other Balance Recoverable 0 Nil 0 627000 627000
64 Fortis Hospitals Limited Fortis Cauvery Joint Venture of Subsidiary Any other transaction Other Balance Recoverable 0 Nil 0 1325000 1325000
65 Fortis Hospitals Limited Fortis Cauvery Joint Venture of Subsidiary Any other transaction Provision for Doubtful Receivable 0 Nil 0 1325000 1325000
66 Fortis Hospitals Limited Fortis C-Doc Healthcare Limited Joint venture company Any other transaction Interest Accrued 0 Nil 0 3833000 0
67 Fortis Hospitals Limited Fortis C-Doc Healthcare Limited Joint venture company Any other transaction Provision against Interest Accrued 0 Nil 0 3833000 0
68 Fortis Hospitals Limited Fortis CSR Foundation Joint venture company Any other transaction Sale of goods or services 0 Nil 15014000 0 16000
69 Fortis Hospitals Limited Fortis C-Doc Healthcare Limited Joint venture company Any other transaction Hospital services taken for employees from 0 Nil 153000 0 0
70 Fortis Hospitals Limited Fortis C-Doc Healthcare Limited Joint venture company Any other transaction Interest income 0 Nil 3247000 0 0
71 Fortis Hospitals Limited Ms. Shailaja Chandra Independent Director Any other transaction Director Sitting Fees 0 Nil 35000 0 0
72 Fortis Hospitals Limited Mr. Ravi Rajagopal Independent Director Any other transaction Director Sitting fees 0 Nil 47000 0 0
73 Fortis Hospotel Limited Mr. Indrajit Banerjee Independent Director Any other transaction Director Sitting Fees 0 Nil 59000 0 0
74 Fortis Malar Hospitals Limited Ms. Shailaja Chandra Independent Director Any other transaction Director Sitting fees 800000 Nil 350000 0 0
75 Fortis Malar Hospitals Limited Ms. Suvalaxmi Chakrabarty Independent Director Any other transaction Director Sitting fees 300000 Nil 250000 0 0
76 Hiranandani healthcare private limited Acibadem Teknoloj A.S Enterprises owned or significantly controlled/influenced by subsidiary of holding/ultimate holding company Any other transaction Intangible asset acquired 0 Nil 2051000 0 1736000
77 International Hospital Limited Acibadem Teknoloj A.S Enterprises owned or significantly controlled/influenced by subsidiary of holding/ultimate holding company Any other transaction Intangible asset acquired 0 Nil 308000 0 0
78 International Hospital Limited Ms. Shailaja Chandra Independent Director Any other transaction Director Sitting Fees 0 Nil 71000 0 0
79 Religare Health Trust Trustee Manager RHT Health Trust Associate Company Sale of goods or services 0 Nil 3378000 0 0
Total value of transaction during the reporting period 341131000





Format for Disclosing Outstanding Default on Loans and Debt Securities
Sr. No. Particulars Amount Remarks
1. Loans / revolving facilities like cash credit from banks / financial institutions
A Total amount outstanding as on date 17457700000
B Of the total amount outstanding, amount of default as on date 0
2. Unlisted debt securities i.e. NCDs and NCRPS
A Total amount outstanding as on date 0
B Of the total amount outstanding, amount of default as on date 0
3. Total financial indebtedness of the listed entity including short-term and long-term debt 17785900000